IPPMed - Institut für Pharmakologie und Präventive Medizin GmbH

Industry / private company


Location: Cloppenburg, Germany (DE) DE

ISNI: 0000000483890378

ROR: https://ror.org/00j0wh784

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Validation of a risk prediction model for early chronic kidney disease in patients with type 2 diabetes: Data from the German/Austrian Diabetes Prospective Follow-up registry. (2023) Kress S, Bramlage P, Holl RW, Möller CD, Mühldorfer S, Reindel J, Seufert J, et al. Journal article The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial (2022) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Journal article THE SGLT2 INHIBITOR EMPAGLIFLOZIN REDUCES TISSUE SODIUM CONTENT IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Conference contribution IMPULSE: The impact of gender on the presentation and management of aortic stenosis across Europe (2021) Steeds RP, Messika-Zeitoun D, Thambyrajah J, Serra A, Schulz E, Maly J, Aiello M, et al. Journal article Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes (2020) Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, et al. Journal article Symptoms, disease severity and treatment of adults with a new diagnosis of severe aortic stenosis (2019) Frey N, Steeds RP, Rudolph TK, Thambyrajah J, Serra A, Schulz E, Maly J, et al. Journal article Patient preference for therapies in hypertension: a cross-sectional survey of German patients (2019) Schmieder R, Högerl K, Jung S, Bramlage P, Veelken R, Ott C Journal article